Geron
GERN
#6280
Rank
ยฃ0.62 B
Marketcap
ยฃ0.98
Share price
3.15%
Change (1 day)
-68.48%
Change (1 year)

Revenue for Geron (GERN)

Revenue in 2025 (TTM): ยฃ0.13 Billion

According to Geron's latest financial reports the company's current revenue (TTM ) is ยฃ0.13 Billion. In 2024 the company made a revenue of ยฃ61.35 Million an increase over the revenue in the year 2023 that were of ยฃ0.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Geron from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.13 B127.16%
2024 ยฃ61.35 M32881.14%
2023 ยฃ0.18 M-62.24%
2022 ยฃ0.49 M-52.26%
2021 ยฃ1.03 M455.99%
2020 ยฃ0.18 M-47.09%
2019 ยฃ0.35 M-58.23%
2018 ยฃ0.83 M6.57%
2017 ยฃ0.78 M-84.22%
2016 ยฃ4.99 M-79.65%
2015 ยฃ24.54 M3214.08%
2014 ยฃ0.74 M-4.79%
2013 ยฃ0.77 M-53.59%
2012 ยฃ1.67 M6.85%
2011 ยฃ1.56 M-32.04%
2010 ยฃ2.3 M116.39%
2009 ยฃ1.06 M-44.23%
2008 ยฃ1.91 M-50.15%
2007 ยฃ3.83 M129.33%
2006 ยฃ1.67 M894.83%
2005 ยฃ0.16 M
2003 ยฃ0.52 M-25.26%
2002 ยฃ0.7 M-71.6%
2001 ยฃ2.49 M-43.62%
2000 ยฃ4.42 M31.38%
1999 ยฃ3.37 M-17.58%
1998 ยฃ4.08 M-7.98%
1997 ยฃ4.44 M43.57%
1996 ยฃ3.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
ยฃ0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ21.83 B 15,759.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.91 B 563.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
ยฃ3.61 B 2,524.33%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ56.87 M-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA